Multiple Myeloma Current Events | Multiple Myeloma News | 3
|
| Page
3 of
13 |
259 Results |
|
|
|
Sort By:
Page Views | Date |
Bisphosphonate drugs reduce the risk of broken bones in breast cancer patients
Bisphosphonate drugs reduce the risk of bone complications when used in patients whose cancer has spread to the bone, according to a new study in the BMJ. view more (2003-08-29)
Experimental procedure induces tolerance to mismatched kidney transplants
Four of five patients participating in a trial of an experimental protocol designed to induce immune tolerance to HLA-mismatched kidney transplants have been able to discontinue immunosuppressive drugs. view more (2008-01-24)
Mayo researchers find race has role in incidence, survival of rare brain tumor
The incidence of a rare and deadly tumor called primary central nervous system lymphoma (PCNSL) is two times higher in black Americans, ages 20 to 49, than in white Americans, according to a Mayo Clinic study published in the June issue of Journal of Neuro-Oncology. view more (2009-07-31)
Sun exposure seems to reduce risk of multiple sclerosis
Higher sun exposure during childhood and early adolescence is associated with a reduced risk of multiple sclerosis, finds a study in this week's BMJ. Multiple sclerosis is more common at higher latitudes, which generally have lower levels of ultraviolet radiation. The study was carried out in Tasmania, which is located at high latitude and has a... view more... (2003-08-06)
Mayo Clinic Cancer Center: Harnessing the measles virus to attack cancer
Mayo Clinic Cancer Center has opened a new clinical study using a vaccine strain of the measles virus to attack recurrent glioblastoma multiforme, a largely untreatable brain tumor. This is the second of several pending molecular medicine studies in patients using measles to kill cancer. view more (2006-10-31)
Ultra-high-field MRI allows for earlier diagnosis of multiple sclerosis
Ultra-high-field (7T) MRI can detect multiple sclerosis lesions better than MRI which can lead to possible earlier diagnosis and treatment. view more (2007-05-07)
Novel anticancer strategy moves from laboratory to clinic
Researchers at Emory University have developed a novel anti-tumor compound that represents a distinct strategy: targeting one of the most important "intercept points" for cancer cells. view more (2008-01-04)
BUDGET FOR INTERFERON BETA FOR MS SUFFERERS WOULD BE BETTER SPENT ON IMPROVED SUPPORTIVE CARE
Dr Raeburn Forbes from Ninewells Hospital and Medical School in Dundee along with colleagues from Argyll and Clyde Health Board and the Scottish Health Purchasing Information Centre studied 132 people with secondary progressive multiple sclerosis and the estimated effect of treating them with interferon beta-1b against existing best practice... view more... (1999-12-08)
Folic Acid Supplements Not Linked To Multiple Births (p 380)
Results of a Chinese population-based study in this week's issue of THE LANCET provide strong evidence that women who take folic acid supplements during pregnancy do not have an increased likelihood of having a multiple birth. Folic acid supplements are recommended for women of childbearing age to prevent neural tube defects-such as spina bifida... view more... (2003-01-29)
Stress makes MS symptoms worse
For patients with multiple sclerosis, stressful life events seem to make their symptoms worse, finds a study in this week’s BMJ. view more (2003-09-17)
New hope for patients with chronic lymphocytic leukemia
Patients treated with lenalidomide for relapsed chronic lymphocytic leukemia (CLL) or disease that no longer responds to chemotherapy have experienced a major response to therapy, according to a phase II study conducted by Asher Chanan-Khan, MD, Department of Medicine, Roswell Park Cancer Institute (RPCI). The results are published in the December... view more... (2006-12-05)
Foxes get frisky in the far north
Bees do it, chimps do it- Now it seems Arctic foxes do it, too. New research looking at the DNA fingerprints of canids in the Far North has revealed that foxes once thought to be monogamous are in fact quite frisky. view more (2007-07-18)
Immune system pathway identified to fight allergens, asthma
For the first time, researchers from the University of Pittsburgh School of Medicine have identified genetic components of dendritic cells that are key to asthma and allergy-related immune response malfunction. view more (2008-05-08)
Government money for multiple sclerosis patients could be better spent
The National Institute for Clinical Excellence (NICE) has announced that neither interferon beta nor glatiramer can be recommended for multiple sclerosis in the NHS. However, the UK government plans to make these drugs available through a risk sharing scheme, despite limited evidence of clinical and cost effectiveness. Researchers in this week's... view more... (2003-02-12)
Mayo Clinic researchers enhance safety and effectiveness of therapeutic virus that fights cancer
Mayo Clinic researchers working with colleagues in Germany have devised a much-needed multilevel safety feature for viruses used to treat cancer. view more (2006-08-01)
Occupational exposure to anaesthetic gases associated with tripling of risk of multiple sclerosis
Occupational exposure to anaesthetic gases may triple the risk of multiple sclerosis, finds a study of nurses in Occupational and Environmental Medicine. view more (2002-12-17)
New imaging technique could promote early detection of multiple sclerosis
Researchers from Purdue University have studied and recorded how myelin degrades real-time in live mice using a new imaging technique. Myelin is the fatty sheath coating the axons, or nerve cells, that insulate and aid in efficient nerve fiber conduction. In diseases such as multiple sclerosis, the myelin sheath has been found to degrade. view more (2007-06-28)
Study may pave way for treatments to delay early multiple births
A treatment that prevents premature births in single pregnancies may be ineffective in women expecting more than one child, a study has shown. view more (2009-06-11)
Study produces conflicting findings on the use of anti-anemia drug in cancer patients
Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo. view more (2007-04-17)
On the trail of a targeted therapy for blood cancers
nvestigators from the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine are focusing on a family of blood proteins that they hope holds a key to decreasing the toxic effects of chemotherapy in children and adults. view more (2008-10-13)
|
|
| Page
3 of
13 |
259 Results |
|
|
|
Sort By:
Page Views | Date |
|
